sahin.io

News

Aether
BiotechSeries A

Launched RapidPrint™, a new polymer product that supercharges high-performance 3D printing (Date not specified)

Company Context

Company Value
$110M
Revenue
Estimated $10M-$25M (Source: LeadIQ)
Market
Biotech
Stage
Series A
Key Highlight

Aether Biomachines raised $15M in December 2025 to scale its AI-designed protein manufacturing.

More from Aether

More Biotech News